Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Will the Analgesics Market Evolve in Terms of Growth and Size by 2029?

The steady expansion of the analgesics market size has been observed in the past few years. It is projected to rise from $110.47 billion in 2024 to $113.1 billion in 2025, with a compound annual growth rate (CAGR) of 2.4%. The growth experienced in the historical period can be traced back to factors like the influence of alternate therapies, safety and efficacy research, prevalence of pain, marketing strategies, and economic factors.

It is anticipated that the analgesics market will sustain a consistent growth in the forthcoming years, reaching a valuation of $127.81 billion by 2029 with a compound annual growth rate (CAGR) of 3.1%. This expansion during the projected period can be ascribed to factors like alternate pain management options, market rivalry, increasing consumer health consciousness, demographic changes, and escalating chronic illnesses. The forecast period will be characterized by key trends such as personalised medication, non-opioid alternatives, the application of CBD and cannabinoids, sophisticated pain management, as well as improving accessibility and affordability.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2438&type=smp

What factors are expected to fuel Analgesics market growth in the coming years?

The increase in the occurrence of chronic illnesses is propelling the analgesics market. Medicines for pain relief, also recognized as analgesics, are utilized to alleviate intense or chronic pain caused by a variety of health conditions. For instance, a report by the World Health Organization (WHO), based in Switzerland, in September 2022 indicates that chronic diseases, often known as noncommunicable diseases (NCDs), manifest over long durations due to the interaction of genetic, physiological, environmental and behavioral factors. NCDs contribute to 41 million deaths annually, representing 74% of global fatalities. Every year, 17 million people under the age of 70 die from NCDs. These premature deaths make up 86% of the total in low and middle-income countries while NCD-related deaths constitute 77% of the total in these nations. As a result, the escalating prevalence of chronic disease is fueling the expansion of the analgesics market.

What Are The Key Findings From The Segmentation Analysis Of The Analgesics Market?

The analgesics market covered in this report is segmented –

1) By Type: Non-opioids, Opioids

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores

3) By Application: Internal Analgesics, External Analgesics

Subsegments:

1) By Non-Opioids: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Acetaminophen (Paracetamol), Salicylates

2) By Opioids: Natural Opioids, Semi-Synthetic Opioids, Synthetic Opioids

Which Trends Are Expected To Shape The Future Of The Analgesics Market?

Significant players in the wound care biologics area are prioritizing the creation of innovative materials such as bioengineered, electrospun synthetic polymer matrix. The goal is to improve healing rates for wounds and encourage tissue redevelopment. Such synthetic polymer matrices, when used in wound care biologics, speed up the healing process and bolster tissue growth. They do this by acting as a structure that promotes cell movement and proliferation. As an example, Royal Biologics, a leader in the orthobiologics and life science field in the US, unveiled two ground-breaking products in October 2024. These were featured at the symposium on advanced wound care and included peak powder collagen matrix and electrofiber 3D. The former aids healing in multiple types of wounds by forming a gel barrier that supports tissue growth, while the latter encourages cell movement and shortens recovery times. These developments have made a profound influence on the wound care biologics market by satisfying the increased need for effective healing methods.

What Are The Most Active Companies In The Analgesics Market Today?

Major companies operating in the analgesics market include Pfizer Inc., Johnson & Johnson Services Inc., Medley Pharmaceuticals Limited, AbbVie Inc., Bayer HealthCare Pharmaceuticals LLC, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Co., AstraZeneca Plc., Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical company Limited, Eli Lilly and Company, Reckitt Benckiser Group plc, Viatris Inc., Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Limited, Purdue Pharma L.P, Cipla Limited, Allergan Inc., Endo International plc, Amneal Pharmaceuticals LLC, Mallinckrodt Pharmaceuticals Ltd., Chattem Inc., Hisamitsu Pharmaceutical Co.Inc., GW Pharmaceuticals, Verve Health Care Ltd., Alder BioPharmaceuticals Inc., Achelios Therapeutics Inc., WEX Pharmaceuticals Inc., Zynerba Pharmaceuticals, McNeil Consumer & Specialty Medical Products, Innovative Med Concepts LLC

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/analgesics-global-market-report

Which Regional Markets Are Attracting The Most Investment In Analgesics?

North America was the largest region in the analgesics market in 2024. Middle East is expected to be the fastest-growing region in the global analgesics market during the forecast period. The regions covered in the analgesics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=2438&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model